H. Jacobs

Cost-effectiveness of neonatal screening for Duchenne muscular dystrophy--how does this compare to existing neonatal screening for metabolic disorders?

J. Horne, R. Thompson, T. Rosenberg, 1993, Social science & medicine.

Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.

C. Greenberg, K. Wrogemann, W. Halliday, 1991, American journal of medical genetics.

GENE STUDIES IN NEWBORN MALES WITH DUCHENNE MUSCULAR DYSTROPHY DETECTED BY NEONATAL SCREENING

C. Greenberg, K. Wrogemann, E. Nylen, 1988, The Lancet.

New horizons in neonatal screening - Lessons from a pilot. Neonatal screening programme for duchenne muscular dystrophy

C. Greenberg, H. Jacobs, 1995 .

Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.

C. Greenberg, J. Evans, K. Wrogemann, 1993, Journal of medical genetics.